CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems

Kenneth J Warrington, Seisuke Takemura, Jörg J. Goronzy, Cornelia M. Weyand

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

Objective. To determine whether CD4+,CD28- T cells, which are expanded in patients with rheumatoid arthritis (RA), express receptors that typically regulate the function of natural killer (NK) cells. Methods. Expression of the NK cell surface molecules CD158, p70, CD94, CD161, and CD8α on T cell subsets was determined by multicolor flow cytometric analysis of peripheral blood mononuclear cells from 36 RA patients. Expression of CD161 on tissue-infiltrating CD4 T cells was determined by 2-color immunohistochemistry analysis of synovial tissue samples. Results. Killer cell-inhibitory receptors (KIR) and killer cell-activating receptors (KAR) were exclusively expressed on CD4+,CD28- T cells, with the CD158b molecule being the most frequently detected isoform. A coordinated mechanism inducing KIR/KAR expression was suggested by similarities in the expression of CD158b on CD4 and CD8 T cells. CD4+,CD28- T cells were also positive for CD8-αα homodimers, another characteristic shared with NK cells. Of the C-type lectin NK cell receptors (NK receptors), CD94 was consistently absent, but CD161 was found on a CD4 T cell population that is significantly expanded in RA patients (P = 0.01). Involvement in disease of NK receptor-expressing CD4 T cells was suggested by the presence of CD4+,CD161+ T cells in follicular microstructures typical of rheumatoid synovitis. Conclusion. Patients with RA have an expanded and unusual subset of CD4 T cells that infiltrates the tissue lesions and is characterized by a deficiency of CD28, the expression of CD8-αα homodimers, and the expression of several types of HLA class I-recognizing NK receptors. CD4 T cells bearing NK receptors can bridge functions of the innate and adaptive immune systems, such as responsiveness to specific antigen, rapid release of interferon-γ, cytotoxicity, independence from classic costimulatory pathways, and integration of multiple activating and inhibitory signals to control effector functions.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalArthritis and Rheumatism
Volume44
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Immune System
Rheumatoid Arthritis
T-Lymphocytes
Natural Killer Cells
KIR Receptors
Natural Killer Cell Receptors
T-Lymphocyte Subsets
C-Type Lectins
CD4 Antigens
Synovitis
Interferons
Blood Cells
Protein Isoforms
Color
Immunohistochemistry
Antigens
Population

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. / Warrington, Kenneth J; Takemura, Seisuke; Goronzy, Jörg J.; Weyand, Cornelia M.

In: Arthritis and Rheumatism, Vol. 44, No. 1, 2001, p. 13-20.

Research output: Contribution to journalArticle

Warrington, Kenneth J ; Takemura, Seisuke ; Goronzy, Jörg J. ; Weyand, Cornelia M. / CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. In: Arthritis and Rheumatism. 2001 ; Vol. 44, No. 1. pp. 13-20.
@article{c843c865897544d1801f52ee4837a6bb,
title = "CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems",
abstract = "Objective. To determine whether CD4+,CD28- T cells, which are expanded in patients with rheumatoid arthritis (RA), express receptors that typically regulate the function of natural killer (NK) cells. Methods. Expression of the NK cell surface molecules CD158, p70, CD94, CD161, and CD8α on T cell subsets was determined by multicolor flow cytometric analysis of peripheral blood mononuclear cells from 36 RA patients. Expression of CD161 on tissue-infiltrating CD4 T cells was determined by 2-color immunohistochemistry analysis of synovial tissue samples. Results. Killer cell-inhibitory receptors (KIR) and killer cell-activating receptors (KAR) were exclusively expressed on CD4+,CD28- T cells, with the CD158b molecule being the most frequently detected isoform. A coordinated mechanism inducing KIR/KAR expression was suggested by similarities in the expression of CD158b on CD4 and CD8 T cells. CD4+,CD28- T cells were also positive for CD8-αα homodimers, another characteristic shared with NK cells. Of the C-type lectin NK cell receptors (NK receptors), CD94 was consistently absent, but CD161 was found on a CD4 T cell population that is significantly expanded in RA patients (P = 0.01). Involvement in disease of NK receptor-expressing CD4 T cells was suggested by the presence of CD4+,CD161+ T cells in follicular microstructures typical of rheumatoid synovitis. Conclusion. Patients with RA have an expanded and unusual subset of CD4 T cells that infiltrates the tissue lesions and is characterized by a deficiency of CD28, the expression of CD8-αα homodimers, and the expression of several types of HLA class I-recognizing NK receptors. CD4 T cells bearing NK receptors can bridge functions of the innate and adaptive immune systems, such as responsiveness to specific antigen, rapid release of interferon-γ, cytotoxicity, independence from classic costimulatory pathways, and integration of multiple activating and inhibitory signals to control effector functions.",
author = "Warrington, {Kenneth J} and Seisuke Takemura and Goronzy, {J{\"o}rg J.} and Weyand, {Cornelia M.}",
year = "2001",
doi = "10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6",
language = "English (US)",
volume = "44",
pages = "13--20",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems

AU - Warrington, Kenneth J

AU - Takemura, Seisuke

AU - Goronzy, Jörg J.

AU - Weyand, Cornelia M.

PY - 2001

Y1 - 2001

N2 - Objective. To determine whether CD4+,CD28- T cells, which are expanded in patients with rheumatoid arthritis (RA), express receptors that typically regulate the function of natural killer (NK) cells. Methods. Expression of the NK cell surface molecules CD158, p70, CD94, CD161, and CD8α on T cell subsets was determined by multicolor flow cytometric analysis of peripheral blood mononuclear cells from 36 RA patients. Expression of CD161 on tissue-infiltrating CD4 T cells was determined by 2-color immunohistochemistry analysis of synovial tissue samples. Results. Killer cell-inhibitory receptors (KIR) and killer cell-activating receptors (KAR) were exclusively expressed on CD4+,CD28- T cells, with the CD158b molecule being the most frequently detected isoform. A coordinated mechanism inducing KIR/KAR expression was suggested by similarities in the expression of CD158b on CD4 and CD8 T cells. CD4+,CD28- T cells were also positive for CD8-αα homodimers, another characteristic shared with NK cells. Of the C-type lectin NK cell receptors (NK receptors), CD94 was consistently absent, but CD161 was found on a CD4 T cell population that is significantly expanded in RA patients (P = 0.01). Involvement in disease of NK receptor-expressing CD4 T cells was suggested by the presence of CD4+,CD161+ T cells in follicular microstructures typical of rheumatoid synovitis. Conclusion. Patients with RA have an expanded and unusual subset of CD4 T cells that infiltrates the tissue lesions and is characterized by a deficiency of CD28, the expression of CD8-αα homodimers, and the expression of several types of HLA class I-recognizing NK receptors. CD4 T cells bearing NK receptors can bridge functions of the innate and adaptive immune systems, such as responsiveness to specific antigen, rapid release of interferon-γ, cytotoxicity, independence from classic costimulatory pathways, and integration of multiple activating and inhibitory signals to control effector functions.

AB - Objective. To determine whether CD4+,CD28- T cells, which are expanded in patients with rheumatoid arthritis (RA), express receptors that typically regulate the function of natural killer (NK) cells. Methods. Expression of the NK cell surface molecules CD158, p70, CD94, CD161, and CD8α on T cell subsets was determined by multicolor flow cytometric analysis of peripheral blood mononuclear cells from 36 RA patients. Expression of CD161 on tissue-infiltrating CD4 T cells was determined by 2-color immunohistochemistry analysis of synovial tissue samples. Results. Killer cell-inhibitory receptors (KIR) and killer cell-activating receptors (KAR) were exclusively expressed on CD4+,CD28- T cells, with the CD158b molecule being the most frequently detected isoform. A coordinated mechanism inducing KIR/KAR expression was suggested by similarities in the expression of CD158b on CD4 and CD8 T cells. CD4+,CD28- T cells were also positive for CD8-αα homodimers, another characteristic shared with NK cells. Of the C-type lectin NK cell receptors (NK receptors), CD94 was consistently absent, but CD161 was found on a CD4 T cell population that is significantly expanded in RA patients (P = 0.01). Involvement in disease of NK receptor-expressing CD4 T cells was suggested by the presence of CD4+,CD161+ T cells in follicular microstructures typical of rheumatoid synovitis. Conclusion. Patients with RA have an expanded and unusual subset of CD4 T cells that infiltrates the tissue lesions and is characterized by a deficiency of CD28, the expression of CD8-αα homodimers, and the expression of several types of HLA class I-recognizing NK receptors. CD4 T cells bearing NK receptors can bridge functions of the innate and adaptive immune systems, such as responsiveness to specific antigen, rapid release of interferon-γ, cytotoxicity, independence from classic costimulatory pathways, and integration of multiple activating and inhibitory signals to control effector functions.

UR - http://www.scopus.com/inward/record.url?scp=0035147101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035147101&partnerID=8YFLogxK

U2 - 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6

DO - 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6

M3 - Article

C2 - 11212151

AN - SCOPUS:0035147101

VL - 44

SP - 13

EP - 20

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 1

ER -